Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock,$0.001 par value per share
- Total 13F shares
- 55,655,238
- Total 13F value
- $64,573,024
- Share change
- -2,898,178
- SEC-reported price per share
- $1.16
- Number of holders
- 115
- Value change
- -$4,209,380
- Number of buys
- 54
- Number of sells
- 81
- Shares outstanding
- 72,096,078
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
115
Top holders
10
ZNTL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98943L107
Recent filing periods:
Ownership snapshot
Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Walters William T.
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Walters William T.
Showing 1-6 of 15 holder rows.
Quick read
Walters William T. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Walters William T.'s linked filing trail.
Comparable ownership
Top 5
Walters William T.
9.9%
VANGUARD GROUP INC
4.6%
BlackRock, Inc.
2.2%
FMR LLC
0.2%
Matrix Capital Management Company...
19%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Walters William T. |
13D/G
|
9.9%
|
$10,081,500
7,050,000 shares
|
+$786,500 | 29 Jan 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.6%
from 13D/G
|
$5,184,373
3,260,612 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
2.2%
from 13D/G
|
$6,724,900
4,229,497 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
13D/G
Company
|
0.2%
from 13D/G
|
$289,682
182,190 shares
|
— | 31 Mar 2025 |
| Matrix Capital Management Company, LP |
13F
Company
|
19%
|
$22,196,357
13,959,973 shares
|
— | 31 Mar 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
4.3%
|
$4,880,527
3,069,514 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
115
Shares
55,655,238
Rows available
115
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
131
Q2 2025 holders
115
Holder diff
-16
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend